Psychotherapy in motion: 3MDR
Submission type
Symposium
Scheduled
Parallel Session III: Administratiezaal, 08-06-2018, 13:00 - 14:30
Beknopte samenvatting van de totale bijdrage
Multi-modular Motion-assisted Memory Desensitisation and Reconsolidation (3MDR) is a high-intensive, innovative psychotherapy for Posttraumatic Stress Disorder (PTSD). Using movement, virtual reality, music and personalisation of treatment, we aim to intensify and enhance treatment. In this symposium we present the theoretical framework, case reports (UK and the Netherlands) and future implications.
Auteurs
Theoretical Approach to 3MDR
Nijdam, M. (Mirjam)
Abstract ID
1294
Submission type
Oral only
Introductie
Since posttraumatic stress disorder (PTSD) can have long-lasting and profound consequences, effective treatment is essential (Schnyder & Cloitre, 2015). The effectiveness of established evidence-based trauma treatments is limited in patient groups such as combat soldiers and first responders who have experienced a multitude of traumatic events (Steenkamp, Litz, Hoge & Marmar, 2015; Haugen, Evces & Weiss, 2012). For this reason Multi-modular Motion-assisted Memory Desensitisation and Reconsolidation (3MDR; (Vermetten, Meijer, Van der Wurff & Mert, 2013)) was developed. 3MDR is based on principles of virtual reality exposure therapy (VRET; (Rizzo, Reger, Gahm, Difede, & Rothbaum, 2009) and EMDR (Shapiro, 1989) embedded in a context in which the patient walks on a treadmill while interacting with a series of self-selected pictures that are displayed on a large screen, resulting in a highly intensive exposure-based therapy. Walking during treatment creates an ‘openness’, stimulates creativity (Oppezzo & Schwartz, 2014) provides positive bodily feedback, allows for tension relief and enhances adaptive reconsolidation processes (Powers et al., 2015). By targeting behavioral and cognitive avoidance with assembly of personal material, 3MDR is in line with the call for personalized medicine (Insel, 2014).
Auteurs
Case reports from a UK and Dutch perspective
Groot, D. de (Dorien),
Kitchiner, N. (Neil)
Abstract ID
1295
Submission type
Oral only
Introductie
The British Forces has seen an increase in chronic cases of PTSD. Despite efforts at optimizing treatment effect the results are not always optimal. Recently the British charity Forces in Mind has funded a RCT for servicemen with chronic combat-related PTSD. A team has been assembled for working with the novel approach of 3MDR. In finding optimal treatment response a RCT has been designed specifically for this treatment resistant population. After initial set up, six therapist have been trained in this treatment method. To date 13 participants have been randomised and three have completed the 3MDR treatment. In the Netherlands the Top Referent Traumacenter in Beilen has also embarked on working with 3MDR. A team of four therapists has been trained and started to provide treatment with chronic patients with PTSD. After the first half year working in over 15 patients the team is motivated to further exposure this approach. Data collected are part of a larger RCT on treatment resistant PTSD. Both partners will present case reports from their current experience and reflect on the lessons learned from working with 3MDR in this difficult to treat population.
Auteurs
Global Consortium and Future Perspective
Schöls, K. (Karlijn)
Abstract ID
1296
Submission type
Oral only
Introductie
Multi-Modular Motion-assisted Memory Desensitisation and Reconsolidation (3MDR) has been developed in the Netherlands but has drawn the interest of multiple international partners, which resulted in an international 3MDR consortium. 3MDR is currently studied in the Netherlands, Wales (UK), Israel, Canada and the United States. In the Netherlands two randomised controlled trials (RCT) are conducted: the 3MDR veteran and the Walk&Talk study. The former focuses on 3MDR as an added intervention for therapy-resistant veterans who did not respond to, or were unable to engage with, current first line treatments. The latter focuses on 3MDR as a stand-alone treatment for patients with work-related PTSD and compares 3MDR to treatment as usual (EMDR, TF-CBT, NET or BEPP). During a proof of concept (Vermetten et al., 2013) patients reported a decrease in PTSD symptoms, a sense of victory, a feeling of control and increased motivation to go on to further treatment despite its high emotional involvement. Therapeutic adherence was high resulting in no drop-out. In addition to the clinical trials our partner in technology, Motek Medical, is further developing the hard- and software of 3MDR. An digital application is under construction, so therapist will be able to control the installation during sessions.
Auteurs
Auteurs
